No Data
No Data
Madrigal Pharmaceuticals Insider Sold Shares Worth $4,787,404, According to a Recent SEC Filing
Fred B Craves, Director, on May 14, 2024, sold 22,489 shares in Madrigal Pharmaceuticals (MDGL) for $4,787,404. Following the Form 4 filing with the SEC, Craves has control over a total of 489,685 sha
Madrigal Pharmaceuticals(MDGL.US) Director Sells US$4.79 Million in Common Stock
$Madrigal Pharmaceuticals(MDGL.US)$ Director CRAVES FRED B sold 22,489 shares of common stock on May 14, 2024 at an average price of $212.8776 for a total value of $4.79 million.Source: Announcement W
Paulson & Co's Top Buy and Sells in Q1
John Paulson's Strategic Moves in Q1 2024 Highlight Madrigal Pharmaceuticals' Prominent Role
Form 144 | Madrigal Pharmaceuticals(MDGL.US) Director Proposes to Sell 4.75 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Madrigal Pharmaceuticals(MDGL.US)$ Director FRED CRAVES intends to sell 22,489 shares of its common stock on May 14, with a total market value of approximately $4.75 m
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), Akero Therapeutics (AKRO) and Madrigal Pharmaceuticals (MDGL)